|Mr. Boris Alexis Jordan||Exec. Chairman||N/A||N/A||1966|
|Mr. Joseph Lusardi||Pres, CEO & Director||N/A||N/A||1974|
|Mr. Neil P. Davidson CPA||CFO & Treasurer||N/A||N/A||1972|
|Mr. Stuart Anthony Wilcox||Chief Operating Officer||N/A||N/A||1961|
|Mr. Daniel P. Foley||VP of Fin. & Investor Relations||N/A||N/A||N/A|
Curaleaf Holdings, Inc. operates as an integrated medical and wellness cannabis operator in the United States. It cultivates, processes, markets, and/or dispenses a range of cannabis products, such as vape oils and concentrates; flower, pre-rolls, and flower pods; topical lotions; capsules and tinctures; mints and lozenges; and edibles. The company also provides hemp-based CBD products. As of September 18, 2019, it operated 49 dispensaries, 14 cultivation sites, and 13 processing sites in 12 states. The company was founded in 2010 and is headquartered in Wakefield, Massachusetts.
Curaleaf Holdings, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.